Yield10 Bioscience, Inc. (YTENQ)

Market Cap	1.00 -98.6%
Revenue (ttm)	750.00K +190.7%
Net Income	-12.70M
EPS	-24.93
Shares Out	734.41K
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	133
Open	0.000001
Previous Close	0.000001
Day's Range	0.000001 - 0.000001
52-Week Range	0.000001 - 0.0002
Beta	31.17
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Yield10 Bioscience

Yield10 Bioscience, Inc. operates as an agricultural bioscience company that focuses on commercializing products using the Camelina oilseeds in the United States. Its products include Camelina oil for production of high levels of the omega-3 fatty acids eicosapentanoic acid (EPA) and docosahexanoic acid (DHA); and for use as a low-carbon intensity feedstock oil for biofuels, including biodiesel, renewable diesel (RD), and sustainable aviation fuel (SAF). The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscienc...

• Industry: Agricultural Inputs
• Sector: Materials
• Founded: 1992
• Employees: 29
• Stock Exchange: OTCMKTS
• Ticker Symbol: YTENQ

Financial Performance

In 2023, Yield10 Bioscience's revenue was $60,000, a decrease of -86.67% compared to the previous year's $450,000. Losses were -$14.46 million, 6.55% more than in 2022.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Oct 17, 2026

Data Sources Report a data error